Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment. [electronic resource] by
- Murphy, G P
- Tjoa, B A
- Simmons, S J
- Ragde, H
- Rogers, M
- Elgamal, A
- Kenny, G M
- Troychak, M J
- Salgaller, M L
- Boynton, A L
Producer: 19990527
In:
The Prostate vol. 39
Availability: No items available.
|
|
|
15.
|
Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA). [electronic resource] by
- Salgaller, M L
- Lodge, P A
- McLean, J G
- Tjoa, B A
- Loftus, D J
- Ragde, H
- Kenny, G M
- Rogers, M
- Boynton, A L
- Murphy, G P
Producer: 19980507
In:
The Prostate vol. 35
Availability: No items available.
|
|
|
16.
|
Cancer immunotherapy for prostate cancer. [electronic resource] by
- Tjoa, B. A
- Erickson, S. J
- Bowes, V. A
- Salgaller, M. L
- Lodge, P. A
- McLean, J. G
- Ragde, H
- Kenny, G. M
- Boynton, A. L
- Murphy, G. P
Publication details: The Canadian journal of urology Jun 1997
In:
The Canadian journal of urology vol. 4
Availability: No items available.
|
|
|
17.
|
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. [electronic resource] by
- Tjoa, B A
- Erickson, S J
- Bowes, V A
- Ragde, H
- Kenny, G M
- Cobb, O E
- Ireton, R C
- Troychak, M J
- Boynton, A L
- Murphy, G P
Producer: 19970930
In:
The Prostate vol. 32
Availability: No items available.
|
|
|
18.
|
Measurement of prostate-specific membrane antigen in the serum with a new antibody. [electronic resource] by
- Murphy, G P
- Tino, W T
- Holmes, E H
- Boynton, A L
- Erickson, S J
- Bowes, V A
- Barren, R J
- Tjoa, B A
- Misrock, S L
- Ragde, H
- Kenny, G M
Producer: 19960503
In:
The Prostate vol. 28
Availability: No items available.
|
|
|
19.
|
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. [electronic resource] by
- Tjoa, B A
- Simmons, S J
- Bowes, V A
- Ragde, H
- Rogers, M
- Elgamal, A
- Kenny, G M
- Cobb, O E
- Ireton, R C
- Troychak, M J
- Salgaller, M L
- Boynton, A L
- Murphy, G P
Producer: 19980716
In:
The Prostate vol. 36
Availability: No items available.
|
|
|
20.
|
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease. [electronic resource] by
- Murphy, G P
- Tjoa, B A
- Simmons, S J
- Jarisch, J
- Bowes, V A
- Ragde, H
- Rogers, M
- Elgamal, A
- Kenny, G M
- Cobb, O E
- Ireton, R C
- Troychak, M J
- Salgaller, M L
- Boynton, A L
Producer: 19990223
In:
The Prostate vol. 38
Availability: No items available.
|